|
Re: Statistical Significance
|
3
|
Resverlogix Corp.
|
Apr 13, 2019 10:21AM
|
|
Resverlogix: The Science Is Getting 'BETter' For RVX208
|
3
|
Resverlogix Corp.
|
Feb 27, 2017 11:31AM
|
|
Re: Tundup's message
|
3
|
Resverlogix Corp.
|
Apr 13, 2019 10:31AM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Aug 18, 2019 06:54PM
|
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Feb 21, 2018 05:45PM
|
|
Re: Bear AZ
|
3
|
Resverlogix Corp.
|
Sep 25, 2019 10:15PM
|
|
Re: Renal trial delayed (again)
|
3
|
Resverlogix Corp.
|
Dec 15, 2017 04:47PM
|
|
Zenith BIO CEO & Investor Conference 2017 Slides
|
3
|
Zenith Epigenetics
|
Feb 14, 2017 12:17PM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
3
|
Zenith Epigenetics
|
Mar 03, 2017 02:07PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 08:04PM
|
|
Re: Could ABET Have Anti-Viral Activity?
|
3
|
Resverlogix Corp.
|
Feb 25, 2020 10:03AM
|
|
Re: Clarification received...
|
3
|
Resverlogix Corp.
|
Jun 09, 2018 09:18PM
|
|
Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
3
|
Resverlogix Corp.
|
Aug 07, 2018 07:12AM
|
|
Re: $ Due to RVX
|
3
|
Zenith Epigenetics
|
Mar 17, 2016 12:33PM
|
|
Re: BIO International June 6-9
|
3
|
Resverlogix Corp.
|
May 26, 2016 01:24PM
|
|
Re: Slide 27 - I would get rid of it....
|
3
|
Resverlogix Corp.
|
Sep 17, 2016 06:03PM
|
|
Re: What if BETonMACE had more CKD patients?
|
3
|
Resverlogix Corp.
|
Dec 27, 2019 08:09AM
|
|
Re: Amarin
|
3
|
Resverlogix Corp.
|
Apr 05, 2018 10:27AM
|
|
Re: New shares issued?
|
3
|
Zenith Epigenetics
|
Aug 12, 2018 05:44PM
|
|
Re: Zenith Epigenetics Corp. Commences Operations
|
3
|
Zenith Epigenetics
|
Dec 09, 2015 12:35PM
|
